In the latest session, Exelixis Inc. (NASDAQ: EXEL) closed at $19.03 down -1.53% from its previous closing price of $19.33. In other words, the price has decreased by -$0.30 from its previous closing price. On the day, 2220562 shares were traded. EXEL stock price reached its highest trading level at $19.30 during the session, while it also had its lowest trading level at $18.75.
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
For a deeper understanding of Exelixis Inc.’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.70 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 23.30. For the most recent quarter (mrq), Quick Ratio is recorded 4.90 and its Current Ratio is at 5.00. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Apr 05 when Hessekiel Jeffrey sold 38,930 shares for $20.01 per share. The transaction valued at 778,989 led to the insider holds 582,435 shares of the business.
WYSZOMIERSKI JACK L sold 15,300 shares of EXEL for $254,133 on Mar 10. The Director now owns 317,467 shares after completing the transaction at $16.61 per share. On Mar 01, another insider, Hessekiel Jeffrey, who serves as the EVP, General Counsel & Sec of the company, sold 77,860 shares for $17.13 each. As a result, the insider received 1,333,742 and left with 527,716 shares of the company.
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EXEL now has a Market Capitalization of 6.30B and an Enterprise Value of 5.18B. As of this moment, Exelixis’s Price-to-Earnings (P/E) ratio for their current fiscal year is 40.32, and their Forward P/E ratio for the next fiscal year is 21.03. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.49. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.71 while its Price-to-Book (P/B) ratio in mrq is 2.41. Its current Enterprise Value per Revenue stands at 3.11 whereas that against EBITDA is 30.42.
Stock Price History:
Over the past 52 weeks, EXEL has reached a high of $22.47, while it has fallen to a 52-week low of $14.87. The 50-Day Moving Average of the stock is 19.11, while the 200-Day Moving Average is calculated to be 17.50.
For the past three months, EXEL has traded an average of 3.02M shares per day and 2.16M over the past ten days. A total of 324.42M shares are outstanding, with a floating share count of 315.46M. Insiders hold about 0.70% of the company’s shares, while institutions hold 88.10% stake in the company. Shares short for EXEL as of May 14, 2023 were 7.41M with a Short Ratio of 7.41M, compared to 6.77M on Apr 13, 2023. Therefore, it implies a Short% of Shares Outstanding of 2.28% and a Short% of Float of 2.59%.
There are 11 different market analysts currently analyzing its stock. On average, analysts expect EPS of $0.14 for the current quarter, with a high estimate of $0.22 and a low estimate of $0.06, while EPS last year was $0.22. The consensus estimate for the next quarter is $0.16, with high estimates of $0.25 and low estimates of $0.06.
Analysts are recommending an EPS of between $0.98 and $0.28 for the fiscal current year, implying an average EPS of $0.62. EPS for the following year is $0.9, with 12 analysts recommending between $1.55 and $0.21.
A total of 13 analysts believe the company’s revenue will be $445.15M this quarter.It ranges from a high estimate of $461.2M to a low estimate of $415M. As of the current estimate, Exelixis Inc.’s year-ago sales were $419.43M, an estimated increase of 6.10% from the year-ago figure. For the next quarter, 13 analysts are estimating revenue of $467.64M, an increase of 13.60% over than the figure of $6.10% in the same quarter last year. There is a high estimate of $489.29M for the next quarter, whereas the lowest estimate is $433M.
A total of 15 analysts have provided revenue estimates for EXEL’s current fiscal year. The highest revenue estimate was $1.88B, while the lowest revenue estimate was $1.7B, resulting in an average revenue estimate of $1.82B. In the same quarter a year ago, actual revenue was $1.61B, up 13.00% from the average estimate. Based on 15 analysts’ estimates, the company’s revenue will be $2.08B in the next fiscal year. The high estimate is $2.26B and the low estimate is $1.78B. The average revenue growth estimate for next year is up 14.10% from the average revenue estimate for this year.